PlainRecalls
FDA Drug Moderate Class II Terminated

Pergolide Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

Reported: April 29, 2015 Initiated: November 14, 2014 #D-837-2015

Product Description

Pergolide Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

Reason for Recall

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Details

Recalling Firm
Attix Pharmaceuticals
Units Affected
1953 grams
Distribution
Nationwide to compounding pharmacies and research organizations.
Location
Toronto

Frequently Asked Questions

What product was recalled?
Pergolide Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada. Recalled by Attix Pharmaceuticals. Units affected: 1953 grams.
Why was this product recalled?
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 29, 2015. Severity: Moderate. Recall number: D-837-2015.